Maven Income & Growth VCT issues 9.9 million new shares

Maven Income and Growth VCT PLC issued 9,866,080 new ordinary shares at prices between 36.18p and 38.29p, bringing total shares outstanding to 209,874,482; the allotment followed £3,679,835 of valid applications for the 2025/26 tax year and is the third and final allotment for that year. The offer (launched Oct 2, 2025) seeks up to £7.5m with a £5m over-allotment, has attracted £12,319,641 of applications to date across two tax years, and the new shares are expected to be admitted to LSE trading around April 8, 2026, with further allotment activity planned in mid-April for 2026/27.

Analysis

This allotment cycle is a liquidity event for the UK VCT ecosystem more than a standalone capital story: incremental primary issuance increases tradable free float and tends to compress illiquidity premia that many legacy VCT holders enjoy. Expect secondary discounts/premiums to reprice within weeks as market makers absorb new supply and re-establish bid density; historically a 3–7% increase in free float can move closed‑end fund discounts by 50–150bps in the short term. That reprice is non-linear — thinly traded names will see larger moves and intraday volatility spikes, creating trading windows but also execution risk for large block sellers.

Operationally, the real runway question is deployment: newly raised cash typically sits on the balance sheet for months, creating cash drag and push‑forward valuation risk if managers feel compelled to deploy into frothy deal markets. If deal flow stalls or competition drives entry valuations higher, NAV generation will lag and the market will front‑run that outcome within 1–6 months. Regulatory or tax tweaks are tail risks on a 12–36 month horizon; even discussion of changes can compress demand for tax‑wrappers and reverse inflows sharply.

The clearest second‑order beneficiaries are distribution platforms and wealth managers that capture recurring fees from primary offers and SIPPs — this is a cash flow story with short lead times. Conversely, small, low‑liquidity VCTs and advisers heavily exposed to legacy portfolios face margin compression and elevated redemption/liquidity risk. Near term, watch market‑maker inventories and platform flow prints as leading indicators — a persistent widening of bid/offer quotes signals the repricing is ongoing and a tactical entry window is closing.

Key Decisions for Investors

• Long AJB.L (AJ Bell) 3–6 months: buy on weakness into flow prints; thesis is +25–40% upside if primary offer volumes sustain platform revenues, downside ~20% if issuance momentum abates. Position sizing 2–4% portfolio, stop‑loss 12%.
• Long HGT.L (HgCapital Trust) 6–18 months: private equity/illiquid-asset managers re‑rate when retail appetite for tax‑efficient wrappers rises; target 15–30% upside versus 20% downside if NAV marks deteriorate. Accumulate on >8% pullback.
• Pair trade (3–6 weeks): short selected small, low‑liquidity VCTs that show immediate tightening of bid/offers and trade at premiums to NAV (identify via platform spreads) and long AJB.L as a hedge to platform flow news. Aim for 1.5:1 reward:risk, tighten stops if spreads normalize.
• Event hedge: buy short‑dated puts (1–3 months) on small‑cap UK fund wrappers or use a market‑neutral volatility package if you hold legacy VCTs — protects against a rapid downside repricing while keeping upside if NAV proves resilient.